-
1
-
-
84886009591
-
CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010
-
Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-oncol. 2013;15(suppl 2):ii1-ii56.
-
(2013)
Neuro-oncol
, vol.15
, pp. ii1-ii56
-
-
Ostrom, Q.T.1
Gittleman, H.2
Farah, P.3
-
2
-
-
0024308795
-
National survey of patterns of care for brain-tumor patients
-
Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg. 1989;71:826-836.
-
(1989)
J Neurosurg
, vol.71
, pp. 826-836
-
-
Mahaley, M.S.1
Mettlin, C.2
Natarajan, N.3
Laws, E.R.4
Peace, B.B.5
-
3
-
-
0030028056
-
Radiation necrosis or recurrence
-
Levivier M, Becerra A, De Witte O, Brotchi J, Goldman S. Radiation necrosis or recurrence. J Neurosurg. 1996;84:148-149.
-
(1996)
J Neurosurg
, vol.84
, pp. 148-149
-
-
Levivier, M.1
Becerra, A.2
De Witte, O.3
Brotchi, J.4
Goldman, S.5
-
4
-
-
0030965006
-
Chemotherapy response criteria in malignant glioma
-
Grant R, Liang BC, Slattery J, Greenberg HS, Junck L. Chemotherapy response criteria in malignant glioma. Neurology. 1997;48:1336-1340.
-
(1997)
Neurology
, vol.48
, pp. 1336-1340
-
-
Grant, R.1
Liang, B.C.2
Slattery, J.3
Greenberg, H.S.4
Junck, L.5
-
5
-
-
84864386757
-
New PET radiopharmaceuticals beyond FDG for brain tumor imaging
-
Gulyás B, Halldin C. New PET radiopharmaceuticals beyond FDG for brain tumor imaging. Q J Nucl Med Mol Imaging. 2012;56:173-190.
-
(2012)
Q J Nucl Med Mol Imaging
, vol.56
, pp. 173-190
-
-
Gulyás, B.1
Halldin, C.2
-
6
-
-
0020000689
-
18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain
-
Patronas NJ, Di Chiro G, Brooks RA, et al. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology. 1982;144:885-889.
-
(1982)
Radiology
, vol.144
, pp. 885-889
-
-
Patronas, N.J.1
Di Chiro, G.2
Brooks, R.A.3
-
8
-
-
0032231697
-
Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography?
-
Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR. 1998;19:407-413.
-
(1998)
AJNR
, vol.19
, pp. 407-413
-
-
Ricci, P.E.1
Karis, J.P.2
Heiserman, J.E.3
Fram, E.K.4
Bice, A.N.5
Drayer, B.P.6
-
9
-
-
0027442743
-
Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo?
-
Ishiwata K, Kubota K, Murakami M, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med. 1993;34:1936-1943.
-
(1993)
J Nucl Med
, vol.34
, pp. 1936-1943
-
-
Ishiwata, K.1
Kubota, K.2
Murakami, M.3
-
10
-
-
0035095729
-
Radiolabeled amino acids: Basic aspects and clinical applications in oncology
-
Jager PL, VaalburgW, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432-445.
-
(2001)
J Nucl Med
, vol.42
, pp. 432-445
-
-
Jager, P.L.1
Vaalburg, W.2
Pruim, J.3
De Vries, E.G.4
Langen, K.J.5
Piers, D.A.6
-
14
-
-
33746082501
-
18F-FDG PET and evaluation of diagnostic accuracy
-
Chen W, Silverman DH, Delaloye S, et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904-911.
-
(2006)
J Nucl Med
, vol.47
, pp. 904-911
-
-
Chen, W.1
Silverman, D.H.2
Delaloye, S.3
-
15
-
-
79851498484
-
18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas
-
Fueger BJ, Czernin J, Cloughesy T, et al. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. J Nucl Med. 2010;51:1532-1538.
-
(2010)
J Nucl Med
, vol.51
, pp. 1532-1538
-
-
Fueger, B.J.1
Czernin, J.2
Cloughesy, T.3
-
16
-
-
0029740689
-
F-Dopa as an amino acid tracer to detect brain tumors
-
Heiss WD, Wienhard K, Wagner R, et al. F-Dopa as an amino acid tracer to detect brain tumors. J Nucl Med. 1996;37:1180-1182.
-
(1996)
J Nucl Med
, vol.37
, pp. 1180-1182
-
-
Heiss, W.D.1
Wienhard, K.2
Wagner, R.3
-
17
-
-
4043130985
-
18F-FDOPA PET
-
Becherer A, Szabo M, Karanikas G, et al. Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med. 2004;45:1161-1167.
-
(2004)
J Nucl Med
, vol.45
, pp. 1161-1167
-
-
Becherer, A.1
Szabo, M.2
Karanikas, G.3
-
18
-
-
0021083984
-
Dopamine visualized in the basal ganglia of living man
-
Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137-138.
-
(1983)
Nature
, vol.305
, pp. 137-138
-
-
Garnett, E.S.1
Firnau, G.2
Nahmias, C.3
-
19
-
-
0032921707
-
18F]fluoroethyl)-L-tyrosine for tumor imaging
-
Wester HJ, Herz M, Weber W, et al. Synthesis and radiopharmacology of O-(2- [18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205-212.
-
(1999)
J Nucl Med
, vol.40
, pp. 205-212
-
-
Wester, H.J.1
Herz, M.2
Weber, W.3
-
20
-
-
84856802355
-
18F-FET) PET for the differential diagnosis of primary brain tumor: A systematic review and metaanalysis
-
Dunet V, Rossier C, Buck A, Stupp R, Prior JO. Performance of 18F-fluoro-ethyltyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and metaanalysis. J Nucl Med. 2012;53:207-214.
-
(2012)
J Nucl Med
, vol.53
, pp. 207-214
-
-
Dunet, V.1
Rossier, C.2
Buck, A.3
Stupp, R.4
Prior, J.O.5
-
21
-
-
24344436347
-
18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas
-
discussion 505-511
-
Rachinger W, Goetz C, Popperl G, et al. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery. 2005;57:505-511, discussion 505-511.
-
(2005)
Neurosurgery
, vol.57
, pp. 505-511
-
-
Rachinger, W.1
Goetz, C.2
Popperl, G.3
-
22
-
-
0033625413
-
11C]methionine uptake in brain tumours: Initial results of a comparative study
-
Weber WA, Wester HJ, Grosu AL, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L- [methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med. 2000;27:542-549.
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 542-549
-
-
Weber, W.A.1
Wester, H.J.2
Grosu, A.L.3
-
23
-
-
84894245592
-
18F-DOPA in PET imaging of recurrent brain tumors
-
Kratochwil C, Combs SE, Leotta K, et al. Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors. Neuro-oncol. 2014;16: 434-440.
-
(2014)
Neuro-oncol
, vol.16
, pp. 434-440
-
-
Kratochwil, C.1
Combs, S.E.2
Leotta, K.3
-
24
-
-
34547122001
-
The 2007 WHO classification of tumours of the central nervous system
-
Louis DN, Ohgaki H,Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109.
-
(2007)
Acta Neuropathol.
, vol.114
, pp. 97-109
-
-
Louis, D.N.1
Ohgaki, H.2
Wiestler, O.D.3
-
25
-
-
0345401521
-
Multiple comparison procedures: The practical solution
-
Saville DJ. Multiple comparison procedures: the practical solution. Amer Statist. 1990;44:174-180.
-
(1990)
Amer Statist
, vol.44
, pp. 174-180
-
-
Saville, D.J.1
-
26
-
-
84855405944
-
18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab
-
Schwarzenberg J, Czernin J, Cloughesy TF, et al. 3′-deoxy-3′-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab. J Nucl Med. 2012;53:29-36.
-
(2012)
J Nucl Med
, vol.53
, pp. 29-36
-
-
Schwarzenberg, J.1
Czernin, J.2
Cloughesy, T.F.3
-
27
-
-
84858595468
-
18F-fluoro- L-phenylalanine PET/CT on managing patients with brain tumors: The referring physician's perspective
-
Walter F, Cloughesy T, Walter MA, et al. Impact of 3,4-dihydroxy-6-18F-fluoro- L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective. J Nucl Med. 2012;53:393-398.
-
(2012)
J Nucl Med
, vol.53
, pp. 393-398
-
-
Walter, F.1
Cloughesy, T.2
Walter, M.A.3
-
28
-
-
84907538239
-
-
Response monitoring trial in patients with suspected recurrence of glioblastoma. Accessed July 24, 2014
-
Response monitoring trial in patients with suspected recurrence of glioblastoma. Clinicaltrials website. http://clinicaltrials.gov/show/NCT01813877. Accessed July 24, 2014.
-
-
-
-
29
-
-
6944250130
-
SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation
-
Lahoutte T, Caveliers V, Camargo SM, et al. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. J Nucl Med. 2004;45: 1591-1596.
-
(2004)
J Nucl Med
, vol.45
, pp. 1591-1596
-
-
Lahoutte, T.1
Caveliers, V.2
Camargo, S.M.3
-
30
-
-
33646046494
-
18F]fluoroethyl)-L-tyrosine: Uptake mechanisms and clinical applications
-
Langen KJ, Hamacher K, Weckesser M, et al. O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
-
(2006)
Nucl Med Biol
, vol.33
, pp. 287-294
-
-
Langen, K.J.1
Hamacher, K.2
Weckesser, M.3
-
32
-
-
0036321187
-
18F]fluoroethyl)- L-tyrosine (FET): A tracer for differentiation of tumour from inflammation in murine lymph nodes
-
Rau FC, Weber WA, Wester HJ, et al. O-(2-[18F]fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging. 2002;29:1039-1046.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 1039-1046
-
-
Rau, F.C.1
Weber, W.A.2
Wester, H.J.3
-
33
-
-
50449097993
-
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
-
del Amo EM, Urtti A, Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci. 2008;35:161-174.
-
(2008)
Eur J Pharm Sci
, vol.35
, pp. 161-174
-
-
Del Amo, E.M.1
Urtti, A.2
Yliperttula, M.3
-
35
-
-
0036241913
-
18F-FET uptake in experimental soft tissue infection
-
Kaim AH, Weber B, Kurrer MO, et al. 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging. 2002;29:648-654.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 648-654
-
-
Kaim, A.H.1
Weber, B.2
Kurrer, M.O.3
-
36
-
-
55949127644
-
18F]-dihydroxy-phenyl-alanine positron emission tomography
-
Kauhanen S, Seppanen M, Nuutila P. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [18F]-dihydroxy-phenyl-alanine positron emission tomography. J Clin Oncol. 2008;26:5307-5308.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5307-5308
-
-
Kauhanen, S.1
Seppanen, M.2
Nuutila, P.3
-
37
-
-
41149124919
-
11C-5-hydroxytryptophan positron emission tomography
-
Koopmans KP, Neels OC, Kema IP, et al. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxytryptophan positron emission tomography. J Clin Oncol. 2008;26:1489-1495.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1489-1495
-
-
Koopmans, K.P.1
Neels, O.C.2
Kema, I.P.3
-
38
-
-
35348832968
-
18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma
-
Timmers HJ, Hadi M, Carrasquillo JA, et al. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. J Nucl Med. 2007;48:1599-1606.
-
(2007)
J Nucl Med
, vol.48
, pp. 1599-1606
-
-
Timmers, H.J.1
Hadi, M.2
Carrasquillo, J.A.3
-
39
-
-
33645990963
-
18F-FET PET for grading of recurrent gliomas: Is evaluation of uptake kinetics superior to standard methods?
-
Pöpperl G, Kreth FW, Herms J, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med. 2006;47:393-403.
-
(2006)
J Nucl Med
, vol.47
, pp. 393-403
-
-
Pöpperl, G.1
Kreth, F.W.2
Herms, J.3
-
40
-
-
36749085053
-
FET PET for the evaluation of untreated gliomas: Correlation of FET uptake and uptake kinetics with tumour grading
-
Pöpperl G, Kreth FW, Mehrkens JH, et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging. 2007;34:1933-1942.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 1933-1942
-
-
Pöpperl, G.1
Kreth, F.W.2
Mehrkens, J.H.3
|